Afrigen Biologics (Pty) Limited Labs
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Afrigen Biologics (Pty) Limited Labs
Afrigen’s MD, Petro Terblanche, discusses the operational freedom that the WTO intellectual property waiver provides for its COVID-19 vaccine being developed under the wider WHO-backed mRNA technology transfer hub initiative. The executive doesn’t anticipate big pharma pushback but says the alliance will “test the system”, though others believe the waiver in its current form doesn’t count for much.
- Antisense, Oligonucleotides